Its popularity, however, has moved considerably faster than its human evidence base
Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide by Cort Johnson | Apr 6, 2026 | Abilify, Antivirals, Baricitinib, Bezisterim, CCR5 Antagonists, Drugs, GLP-1, Guanfacine, Homepage, Ivabradine, IVIG, JAK_STAT Inhibitors, Low Dose Naltrexone, Mestinon, Rapamycin, Stellate Ganglion Block, Stimulants, Trazodone, Treatment Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think
Seek urgent medical advice if you experience: Severe or recurrent hypoglycaemia (blood sugar below 4 mmol/L) Symptoms of hypoglycaemia that do not improve with treatment Severe, persistent abdominal pain, especially if radiating to the back (this could indicate pancreatitis, a rare but serious side effect of GLP-1 receptor agonists) [2] Persistent or severe gastrointestinal symptoms such as vomiting, severe diarrhoea, or abdominal pain Signs of dehydration (dry mouth, reduced urination, dizziness) Any new or worsening symptoms after starting berberine If you cannot reach your GP and need urgent advice, contact NHS 111
Additionally, participants reported a significant reduction in appetite and cravings, as well as improved control over their eating habits
Some people may use the medication long-term to maintain their results, while others may be able to stop taking it after reaching their goals and successfully adopting new diet and exercise routines
